Free Trial

TimesSquare Capital Management LLC Has $1.41 Million Position in Bowhead Specialty Holdings Inc. (NYSE:BOW)

Bowhead Specialty logo with Finance background

TimesSquare Capital Management LLC cut its holdings in Bowhead Specialty Holdings Inc. (NYSE:BOW - Free Report) by 39.3% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 39,576 shares of the company's stock after selling 25,610 shares during the period. TimesSquare Capital Management LLC owned about 0.12% of Bowhead Specialty worth $1,406,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also modified their holdings of the business. Emerald Mutual Fund Advisers Trust lifted its position in Bowhead Specialty by 0.5% in the 3rd quarter. Emerald Mutual Fund Advisers Trust now owns 194,333 shares of the company's stock valued at $5,443,000 after purchasing an additional 937 shares during the last quarter. New York State Common Retirement Fund bought a new stake in Bowhead Specialty in the 4th quarter valued at about $64,000. The Manufacturers Life Insurance Company lifted its position in Bowhead Specialty by 5.2% in the 3rd quarter. The Manufacturers Life Insurance Company now owns 60,508 shares of the company's stock valued at $1,695,000 after purchasing an additional 2,976 shares during the last quarter. MetLife Investment Management LLC bought a new stake in Bowhead Specialty in the 3rd quarter valued at about $123,000. Finally, New Vernon Investment Management LLC bought a new stake in Bowhead Specialty in the 3rd quarter valued at about $127,000.

Analyst Ratings Changes

BOW has been the topic of a number of recent analyst reports. Royal Bank of Canada boosted their price target on shares of Bowhead Specialty from $32.00 to $35.00 and gave the stock an "outperform" rating in a research report on Wednesday, November 6th. JMP Securities boosted their price target on shares of Bowhead Specialty from $32.00 to $33.00 and gave the stock a "market outperform" rating in a research report on Wednesday, November 6th. Keefe, Bruyette & Woods boosted their price target on shares of Bowhead Specialty from $36.00 to $44.00 and gave the stock a "market perform" rating in a research report on Friday, January 10th. Finally, JPMorgan Chase & Co. boosted their price target on shares of Bowhead Specialty from $26.00 to $30.00 and gave the stock a "neutral" rating in a research report on Thursday, November 7th. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to MarketBeat, Bowhead Specialty presently has a consensus rating of "Hold" and a consensus target price of $33.60.

Get Our Latest Stock Report on Bowhead Specialty

Bowhead Specialty Stock Performance

NYSE BOW traded down $0.61 during trading on Friday, hitting $31.13. The company's stock had a trading volume of 47,293 shares, compared to its average volume of 97,346. The firm has a 50 day moving average price of $33.24 and a 200 day moving average price of $31.68. Bowhead Specialty Holdings Inc. has a 52 week low of $22.14 and a 52 week high of $37.81.

Bowhead Specialty Company Profile

(Free Report)

Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.

See Also

Institutional Ownership by Quarter for Bowhead Specialty (NYSE:BOW)

Should You Invest $1,000 in Bowhead Specialty Right Now?

Before you consider Bowhead Specialty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bowhead Specialty wasn't on the list.

While Bowhead Specialty currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Goldman Sachs' 2025 Market Outlook: Top 3 Stock Picks

Goldman Sachs' 2025 Market Outlook: Top 3 Stock Picks

As Wall Street's 2025 predictions roll in, Goldman Sachs is focusing on manufacturing, energy, and domestic producers as key sectors for growth.

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines